| Year |
Citation |
Score |
| 2020 |
Ono K, Tsuji M, Yamasaki TR, Pasinetti GM. Anti-aggregation Effects of Phenolic Compounds on α-synuclein. Molecules (Basel, Switzerland). 25. PMID 32456274 DOI: 10.3390/Molecules25102444 |
0.339 |
|
| 2019 |
Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337. PMID 30745444 DOI: 10.1212/Wnl.0000000000006926 |
0.425 |
|
| 2018 |
Yamasaki TR, Holmes BB, Furman JL, Dhavale DD, Su BW, Song ES, Cairns NJ, Kotzbauer PT, Diamond MI. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics. The Journal of Biological Chemistry. PMID 30478174 DOI: 10.1074/Jbc.Ra118.004471 |
0.307 |
|
| 2014 |
Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC, Belaygorod L, Cairns NJ, Holtzman DM, Diamond MI. Proteopathic tau seeding predicts tauopathy in vivo. Proceedings of the National Academy of Sciences of the United States of America. 111: E4376-85. PMID 25261551 DOI: 10.1073/Pnas.1411649111 |
0.43 |
|
| 2014 |
Teng E, Yamasaki TR, Tran M, Hsiao JJ, Sultzer DL, Mendez MF. Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 37: 307-14. PMID 24401901 DOI: 10.1159/000355555 |
0.342 |
|
| 2011 |
Lopes JP, Blurton-Jones M, Yamasaki TR, Agostinho P, LaFerla FM. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not aß and tau pathology Advances in Alzheimer's Disease. 1: 139-148. DOI: 10.3233/978-1-60750-733-8-139 |
0.684 |
|
| 2009 |
Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 106: 13594-9. PMID 19633196 DOI: 10.1073/Pnas.0901402106 |
0.658 |
|
| 2009 |
Lopes JP, Blurton-Jones M, Yamasaki TR, Agostinho P, LaFerla FM. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology. Journal of Alzheimer's Disease : Jad. 16: 541-9. PMID 19276549 DOI: 10.3233/Jad-2009-0993 |
0.726 |
|
| 2007 |
Yamasaki TR, Blurton-Jones M, Morrissette DA, Kitazawa M, Oddo S, LaFerla FM. Neural stem cells improve memory in an inducible mouse model of neuronal loss. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11925-33. PMID 17978032 DOI: 10.1523/Jneurosci.1627-07.2007 |
0.651 |
|
| 2005 |
Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8843-53. PMID 16192374 DOI: 10.1523/Jneurosci.2868-05.2005 |
0.706 |
|
| 2004 |
Kitazawa M, Yamasaki TR, LaFerla FM. Microglia as a potential bridge between the amyloid beta-peptide and tau. Annals of the New York Academy of Sciences. 1035: 85-103. PMID 15681802 DOI: 10.1196/Annals.1332.006 |
0.607 |
|
| 2002 |
Sugarman MC, Yamasaki TR, Oddo S, Echegoyen JC, Murphy MP, Golde TE, Jannatipour M, Leissring MA, LaFerla FM. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 99: 6334-9. PMID 11972038 DOI: 10.1073/Pnas.082545599 |
0.697 |
|
| 2000 |
Leissring MA, Yamasaki TR, Wasco W, Buxbaum JD, Parker I, LaFerla FM. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proceedings of the National Academy of Sciences of the United States of America. 97: 8590-3. PMID 10900016 DOI: 10.1073/Pnas.97.15.8590 |
0.632 |
|
| Show low-probability matches. |